Validated five-factor model of Positive and Negative Syndrome Scale for schizophrenia in Chinese population

Schizophrenia Research

Volumn 143, Issue 1, 2013, Pages 38-43

  Jiang, Jundong ^a,b   Sim, Kang ^a   Lee, Jimmy ^a  

^a INSTITUTE OF MENTAL HEALTH   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Factor; PANSS; Schizophrenia

Indexed keywords

ADULT; ARTICLE; ATTENTION DISTURBANCE; CHINESE; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; CULTURAL FACTOR; DEPRESSION; EXCITEMENT; EXPLORATORY RESEARCH; FACTORIAL ANALYSIS; FEMALE; GRANDIOSE DELUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; SCHIZOPHRENIA; VALIDATION PROCESS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PSYCHIATRIC STATUS RATING SCALES; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA;

EID: 84871934312     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.10.019     Document Type: Article

References (41)

1. Bell M.D., Lysaker P.H., Beam-Goulet J.L., Milstein R.M., Lindenmayer J.P. Five-component model of schizophrenia: assessing the factorial invariance of the positive and negative syndrome scale. Psychiatry Res. 1994, 52(3):295-303.
2. Bhugra D., Corridan B., Rudge S., Leff J., Mallett R. Early manifestations, personality traits and pathways into care for Asian and white first-onset case of schizophrenia. Soc. Psychiatry 1999, 34:595-599.
3. Bunk D., Eggers C., Klapal M. Symptom dimensions in the course of childhood-onset schizophrenia. Eur. Child Adolesc. Psychiatry 1999, 8(Suppl. 1):I29-I35.
4. Citrome L., Meng X., Hochfeld M. Efficacy of iloperidone in schizophrenia: a PANSS five-factor analysis. Schizophr. Res. 2011, 131(1-3):75-81.
5. Dollfus S., Petit M. Principal-component analyses of PANSS and SANS-SAPS in schizophrenia: their stability in an acute phase. Eur. Psychiatry 1995, 10(2):97-106.
6. Drake R.J., Dunn G., Tarrier N., Haddock G., Haley C., Lewis S. The evolution of symptoms in the early course of non-affective psychosis. Schizophr. Res. 2003, 63(1-2):171-179.
7. El Yazaji M., Battas O., Agoub M., Moussaoui D., Gutknecht C., Dalery J., D'Amato T., Saoud M. Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia. Schizophr. Res. 2002, 56(1-2):121-127.
8. Emsley R., Rabinowitz J., Torreman M. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophr. Res. 2003, 61(1):47-57.
9. Fitzgerald P.B., De Castella A.R., Brewer K., Filia K., Collins J., Davey P., Rolfe T., Kulkarni J. A confirmatory factor analytic evaluation of the pentagonal PANSS model. Schizophr. Res. 2003, 61(1):97-104.
10. Fredrikson D., Steiger J., MacEwan G., Altman S., Kopala L., Flyn S., Liddle P., Honer W. PANSS symptom factors in schizophrenia. Schizophr. Res. 1997, 24:1-2.
11. Fresan A., De La Fuente-Sandoval C., Loyzaga C., Garcia-Anaya M., Meyenberg N., Nicolini H., Apiquian R. A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients. Schizophr. Res. 2005, 72(2-3):123-129.
12. Higashima M., Urata K., Kawasaki Y., Maeda Y., Sakai N., Mizukoshi C., Nagasawa T., Kamiya T., Yamaguchi N., Koshino Y. P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia. Biol. Psychiatry 1998, 44(2):115-120.
13. Kawasaki Y., Maeda Y., Sakai N., Higashima M., Urata K., Yamaguchi N., Kurachi M. Evaluation and interpretation of symptom structures in patients with schizophrenia. Acta Psychiatr. Scand. 1994, 89(6):399-404.
14. Kay S.R., Sevy S. Pyramidical model of schizophrenia. Schizophr. Bull. 1990, 16(3):537-545.
15. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
16. Kim J.H., Kim S.Y., Lee J., Oh K.J., Kim Y.B., Cho Z.H. Evaluation of the factor structure of symptoms in patients with schizophrenia. Psychiatry Res. 2012, 197(3):285-289.
17. Kline R.B. Principles and Practice of Structural Equation Modeling 2010, Guilford, New York.
18. Krajewski-Jaime E.R. Folk-healing among Mexican-American families as a consideration in the delivery of child welfare and child health care services. Child Welfare 1991, 70(2):157-168.
19. Lancon C., Aghababian V., Llorca P.M., Auquier P. Factorial structure of the Positive and Negative Syndrome Scale (PANSS): a forced five-dimensional factor analysis. Acta Psychiatr. Scand. 1998, 98(5):369-376.
20. Lancon C., Aghababian V., Llorca P.M., Bernard D., Auquier P. An exploration of the psychometric properties of the French version of the Positive and Negative Syndrome Scale. Can. J. Psychiatry 1999, 44(9):893-900.
21. Lancon C., Auquier P., Nayt G., Reine G. Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS). Schizophr. Res. 2000, 42(3):231-239.
22. Lee K.H., Harris A.W., Loughland C.M., Williams L.M. The five symptom dimensions and depression in schizophrenia. Psychopathology 2003, 36(5):226-233.
23. Lehoux C., Gobeil M.H., Lefebvre A.A., Maziade M., Roy M.A. The five-factor structure of the PANSS: a critical review of its consistency across studies. Clin. Schizophr. Relat. Psychoses 2009, (3):103-110.
24. Levine S.Z., Rabinowitz J. Revisiting the 5 dimensions of the Positive and Negative Syndrome Scale. J. Clin. Psychopharmacol. 2007, 27(5):431-436.
25. Lim C.S., Subramaniam M., Poon L.Y., Chong S.A., Verma S. Cross-ethnic differences in severity of symptomatology of individuals with first-episode schizophrenia spectrum disorder. Early Interv. Psychiatry 2011, 5(3):242-248.
26. Lindenmayer J.P., Bernstein-Hyman R., Grochowski S. A new five factor model of schizophrenia. Psychiatr. Q. 1994, 65(4):299-322.
27. Lindenmayer J.P., Bernstein-Hyman R., Grochowski S., Bark N. Psychopathology of schizophrenia: initial validation of a five-factor model. Psychopathology 1995, 28(1):22-31.
28. Lindenmayer J.P., Grochowski S., Hyman R.B. Five factor model of schizophrenia: replication across samples. Schizophr. Res. 1995, 14(3):229-234.
29. Lindström E., Von Knorring L. Principal component analysis of the Swedish version of the Positive and Negative Syndrome Scale for schizophrenia. Nord. J. Psychiatry 1993, 47(4):257-263.
30. Lykouras L., Oulis P., Psarros K., Daskalopoulou E., Botsis A., Christodoulou G.N., Stefanis C. Five-factor model of schizophrenic psychopathology: how valid is it?. Eur. Arch. Psychiatry Clin. Neurosci. 2000, 250(2):93-100.
31. Marder S.R., Davis J.M., Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. J. Clin. Psychiatry 1997, 58(12):538-546.
32. Mass R., Schoemig T., Hitschfeld K., Wall E., Haasen C. Psychopathological syndromes of schizophrenia: evaluation of the dimensional structure of the positive and negative syndrome scale. Schizophr. Bull. 2000, 26(1):167-177.
33. Peralta V., Cuesta M.J. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res. 1994, 53(1):31-40.
34. Van Den Oord E.J., Rujescu D., Robles J.R., Giegling I., Birrell C., Bukszar J., Murrelle L., Moller H.J., Middleton L., Muglia P. Factor structure and external validity of the PANSS revisited. Schizophr. Res. 2006, 82(2-3):213-223.
35. Van Der Gaag M., Cuijpers A., Hoffman T., Remijsen M., Hijman R., De Haan L., Van Meijel B., Van Harten P.N., Valmaggia L., De Hert M., Wiersma D. The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophr. Res. 2006, 85(1-3):273-279.
36. Van Der Gaag M., Hoffman T., Remijsen M., Hijman R., De Haan L., Van Meijel B., Van Harten P.N., Valmaggia L., De Hert M., Cuijpers A., Wiersma D. The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model. Schizophr. Res. 2006, 85(1-3):280-287.
37. Versola-Russo J. Cultural and demographic factors of schizophrenia. Int. J. Psychosoc. Rehabil. 2006, 10(2):89-103.
38. Vieta E., Pappadopulos E., Mandel F.S., Lombardo I. Impact of geographical and cultural factors on clinical trials in acute mania: lessons from a ziprasidone and haloperidol placebo-controlled study. Int. J. Neuropsychopharmacol. 2011, 14(8):1017-1027.
39. Wallwork R.S., Fortgang R., Hashimoto R., Weinberger D.R., Dickinson D. Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia. Schizophr. Res. 2012, 137(1-3):246-250.
40. White L., Harvey P.D., Opler L., Lindenmayer J.P. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. Psychopathology 1997, 30(5):263-274.
41. Wolthaus J.E., Dingemans P.M., Schene A.H., Linszen D.H., Knegtering H., Holthausen E.A., Cahn W., Hijman R. Component structure of the positive and negative syndrome scale (PANSS) in patients with recent-onset schizophrenia and spectrum disorders. Psychopharmacology (Berl) 2000, 150(4):399-403.